Organigram Global Inc. (OGI)
NASDAQ: OGI · Real-Time Price · USD
1.800
-0.120 (-6.25%)
At close: Dec 15, 2025, 4:00 PM EST
1.900
+0.100 (5.56%)
Pre-market: Dec 16, 2025, 6:24 AM EST
Organigram Global Market Cap
Organigram Global has a market cap or net worth of $240.02 million as of December 16, 2025. Its market cap has increased by 54.15% in one year.
Market Cap
240.02M
Enterprise Value
266.71M
1-Year Change
54.15%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since May 21, 2019, Organigram Global's market cap has decreased from $1.01B to $240.02M, a decrease of -76.35%. That is a compound annual growth rate of -19.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 241.20M | 37.99% |
| Dec 31, 2024 | 174.80M | 64.44% |
| Dec 29, 2023 | 106.30M | -57.67% |
| Dec 30, 2022 | 251.10M | -51.98% |
| Dec 31, 2021 | 522.90M | 151.76% |
| Dec 31, 2020 | 207.70M | -45.73% |
| Dec 31, 2019 | 382.70M | -62.29% |
| May 21, 2019 | 1.01B | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |